270 related articles for article (PubMed ID: 34488359)
1. Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study.
Liu XX; Wang HX; Hu YY; Zhu XT; Tan X; Yang Y; Hang YF; Zhu JG
Ann Palliat Med; 2021 Aug; 10(8):8701-8708. PubMed ID: 34488359
[TBL] [Abstract][Full Text] [Related]
2. Drug-related problems in hospitalized patients with chronic kidney diseases and clinical pharmacist interventions.
Zhang S; Zhang GB; Huang P; Ren Y; Lin B; Shao YF; Ye XL
BMC Geriatr; 2023 Dec; 23(1):849. PubMed ID: 38093184
[TBL] [Abstract][Full Text] [Related]
3. Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.
Liu P; Li G; Han M; Zhang C
BMC Pharmacol Toxicol; 2021 Oct; 22(1):65. PubMed ID: 34702348
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
[TBL] [Abstract][Full Text] [Related]
5. Identify and categorize drug-related problems in hospitalized surgical patients in China.
Qu C; Meng L; Wang N; Chen Y; Yang X; Wang J; Sun S; Qiu F
Int J Clin Pharm; 2019 Feb; 41(1):13-17. PubMed ID: 30610549
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
[TBL] [Abstract][Full Text] [Related]
7. Drug-related problems among hospitalized cancer pain patients: an investigative single-arm intervention trial.
Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
Ann Palliat Med; 2021 Feb; 10(2):2008-2017. PubMed ID: 33353357
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacists' interventions on drug-related problems and drug costs in patients with cancer pain.
Zhang P; Lv D; Zhao J; Sun S; Li L; Liao Y
Int J Clin Pharm; 2021 Oct; 43(5):1274-1282. PubMed ID: 33625653
[TBL] [Abstract][Full Text] [Related]
9. Drug-related problems among community-dwelling elderly with ischemic stroke in China.
Tian L; Wu J; Qi Z; Qian S; Zhang S; Song D; Chen B; Zhu D
Adv Clin Exp Med; 2023 Apr; 32(4):423-432. PubMed ID: 36753371
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
[TBL] [Abstract][Full Text] [Related]
12. Drug-related problems among hospitalized patients with COPD in mainland China.
Li Q; Qu HJ; Lv D; Yeh MK; Sun S; Li L; Liao Y
Int J Clin Pharm; 2019 Dec; 41(6):1507-1515. PubMed ID: 31705457
[TBL] [Abstract][Full Text] [Related]
13. Application of comprehensive pharmaceutical care program in identifying and addressing drug-related problems in hospitalized patients with osteoporosis.
Chen W; Zhang H; Jiang J; Zhang X; Ding J; Liu Y; Dang H
BMC Health Serv Res; 2022 Nov; 22(1):1438. PubMed ID: 36443812
[TBL] [Abstract][Full Text] [Related]
14. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China.
Zhu Y; Liu C; Zhang Y; Shi Q; Kong Y; Wang M; Xia X; Zhang F
Int J Clin Pharm; 2019 Dec; 41(6):1570-1577. PubMed ID: 31654364
[TBL] [Abstract][Full Text] [Related]
15. Drug-related problems among community-dwelling older adults in mainland China.
Yang J; Meng L; Liu Y; Lv L; Sun S; Long R; Shan X; Song J; Qiu F
Int J Clin Pharm; 2018 Apr; 40(2):368-375. PubMed ID: 29340850
[TBL] [Abstract][Full Text] [Related]
16. Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study.
Pehlivanli A; Eyupoglu S; Basgut B; Erturk S; Ozcelikay AT
BMC Nephrol; 2023 May; 24(1):149. PubMed ID: 37237342
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Desrochers JF; Lemieux JP; Morin-Bélanger C; Paradis FS; Lord A; Bell R; Berbiche D; Bárcena PQ; Séguin NC; Desforges K; Legris MÈ; Sauvé P; Lalonde L
Am J Kidney Dis; 2011 Oct; 58(4):527-35. PubMed ID: 21778005
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability.
Ahmed NA; Fouad EA; El-Asheer OM; Ghanem ASM
Front Pharmacol; 2024; 15():1391657. PubMed ID: 38873432
[No Abstract] [Full Text] [Related]
19. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
[TBL] [Abstract][Full Text] [Related]
20. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
